ArticleBMC bioinformatics2026
Semisupervised approach for dominant gene selection and classification.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSemisupervised learning has attracted significant interest in gene expression analysis due to its ability to improve classification performance under limited labeled data, a common challenge arising from high dimensionality and small sample sizes. Existing semisupervised methods often rely on manifold learning to propagate label information; however, weak label connections in early learning stages can reduce their effectiveness.
resultsTo address these limitations, we propose a semisupervised approach for dominant gene selection and classification (SADGSC) that employs feature decomposition to identify essential features while suppressing noise and redundancy. The proposed method adopts hinge loss instead of square loss for label prediction and constructs a projection matrix based on confidence-weighted features, leading to improved classification accuracy and interpretability. Biological analysis of the top-ranked genes (e.g., PGR, KRT14, TOX3, and FGF10) reveals enrichment in hormone signaling epithelial-mesenchymal transition, apoptosis, and oxidative stress pathways, demonstrating the biological relevance of the selected genes. Experimental evaluations conducted on eleven datasets, primarily gene expression datasets, show that SADGSC achieves competitive performance compared with state-of-the-art methods.
conclusionsThe proposed SADGSC framework effectively addresses the challenges of limited labeled data and high dimensionality in gene expression analysis, providing strong classification performance and biologically meaningful gene selection. These findings highlight the potential of semisupervised learning for dominant gene discovery and robust classification in high-dimensional biological datasets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.